 |
|
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
|
^ Top
I
Industry Spotlight on Drugs static version printer friendly
Industry Spotlight on Retail - Drug Stores and Proprietary Stores static version printer friendly pdf version
Industry Spotlight on Wholesale - Drugs, Chemicals and Allied Products... static version printer friendly pdf version
Infant Mortality Rate by Country, 2008 static version printer friendly pdf version
Infection Rate of Invasive Pneumococcal Disease in the U.S., 1998-2006... static version printer friendly pdf version
Infection Rate of Serotype 19A by Age Group in the U.S., 1998-2006 static version printer friendly pdf version
Infectious Disease Diagnostics Markets in sub-Saharan Africa static version printer friendly pdf version
Influencing Physician Prescribing: Online Strategies static version printer friendly
Influencing the Development of NICE Technology Appraisals and Guidelin... static version printer friendly pdf version
InfoBase Cd-rom Directory of over 17,000 Life Science Companies and Or... static version printer friendly pdf version
Inhalable Drug Delivery: Industry Holds its Breath in Anticipation of ... static version printer friendly pdf version
Injectable Drug Delivery: Market Impact and Industry Trends static version printer friendly pdf version
Injectable Generic Drugs: Prospects and Opportunities to 2010 static version printer friendly
Innovation Case Study: Novartis static version printer friendly pdf version
Innovation Driving Trauma Market static version printer friendly pdf version
Innovations and Trends in Clinical Trials - Microdosing (Phase 0 Trial... static version printer friendly pdf version
Innovations in Cardiovascular Disease Management: Latest Surgical Proc... static version printer friendly pdf version
Innovative Clinical Trial Design and Management: Trends, Success Stori... static version printer friendly pdf version
Innovative Drug R&D in China static version printer friendly pdf version
Innovative Targeted Therapies - Smart Drugs On Target For Increasing G... static version printer friendly pdf version
Insights into Platform Technology and Early-Stage Pipeline Mergers and... static version printer friendly pdf version
Insomnia - Sanofi-Synthelabo to Drive Growth of This Potentially Lucra... static version printer friendly pdf version
Insomnia: Wake-Up Call for a Sleepy Market static version printer friendly
Instant Clinical Pharmacology, 2nd Edition static version printer friendly pdf version
Insulin Delivery Devices Market Analysis and Future Forecast static version printer friendly pdf version
Integrating Diagnostics and Therapeutics for Targeted Therapies, Part ... static version printer friendly
Integrating Diagnostics and Therapeutics for Targeted Therapies, Part ... static version printer friendly pdf version
Intellectual Property and Outsourcing in China: Minimizing Risk whilst... static version printer friendly pdf version
IntelliNews Bulgarian Pharmaceutical Report static version printer friendly
IntelliNews Romanian Pharmaceutical Report static version printer friendly
Interferons - State-of-the-Science and Strategic Opportunities static version printer friendly
Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists static version printer friendly pdf version
International IT Regulations and Compliance: Quality Standards in the ... static version printer friendly pdf version
International Trends in the Use of Health Technology Assessment static version printer friendly pdf version
Interstitial Cystitis - Few Treatments, Poor Outcome static version printer friendly
Intranasal Drug Delivery - US Market Trends & Analysis static version printer friendly pdf version
Intravascular Ultrasound (IVUS) Market: An Analysis static version printer friendly pdf version
Introduction to Meta-Analysis static version printer friendly pdf version
InvestFrost Healthcare - European Insulin Delivery Devices Market Outl... static version printer friendly pdf version
Ion Channels and G Protein-coupled Receptors (GPCRs) Qualitative and Q... static version printer friendly pdf version
Ipsen: PharmaVitae Profile static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Iran Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Irbesartan - Pipeline Developer static version printer friendly pdf version
Irbesartan - Pipeline Selector static version printer friendly pdf version
Irinotecan - Pipeline Developer static version printer friendly pdf version
Irinotecan - Pipeline Selector static version printer friendly pdf version
Iron Sucrose - Pipeline Developer static version printer friendly pdf version
Iron Sucrose - Pipeline Selector static version printer friendly pdf version
Irritable Bowel Syndrome static version printer friendly pdf version
Is There Commercial Opportunity in the Development of a New Influenza ... static version printer friendly
Isotretinoin - Pipeline Developer static version printer friendly pdf version
Isotretinoin - Pipeline Selector static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Israel Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Issues and Trends in U.S. Outpatient Prescription Drug Reimbursement static version printer friendly pdf version
IT Spending Study At Major Pharma Companies static version printer friendly pdf version
It's All About the Biomarkers: How 2008's Biomarker-Based Partnering I... static version printer friendly pdf version
Italy Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Italy Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Itraconazole - Pipeline Developer static version printer friendly pdf version
Itraconazole - Pipeline Selector static version printer friendly pdf version
ITs role in the evolving pharma industry - Addressing the R&D producti... static version printer friendly
iTV in Pharmaceutical Marketing: Building Customer Relationships Throu... static version printer friendly pdf version
IVD Markets in sub-Saharan Africa static version printer friendly pdf version
Ivermectin & Praziquantel (Vet) - Pipeline Selector static version printer friendly pdf version
^ Top
J
Japan - Pharmaceutical Industry Overview static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Japan Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Japan Quality Audits 2009 static version printer friendly pdf version
Japan: Opening the Door to Global Clinical Trials static version printer friendly pdf version
Japan: Pharmaceutical Market - Future Perspectives (1997 - 2006) static version printer friendly
Japanese Drug Sector: Sector Report static version printer friendly pdf version
Japanese Markets for Urological Devices static version printer friendly pdf version
Japanese Pharmaceutical Industry: Sector Report static version printer friendly pdf version
Japanese Pharmaceutical Sector: Sector Report static version printer friendly pdf version
Johnson & Johnson: Performance, Capabilities, Goals and Strategies in ... static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Jordan Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
^ Top
K
Kazakhstan - Pharmaceutical Industry Overview static version printer friendly pdf version
Kazakhstan Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Kazakhstan Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Kenya - Pharmaceutical Industry Overview static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Kenya Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Key Factors in U.S. Pharmaceutical Pricing static version printer friendly pdf version
Key ID market events 2002 static version printer friendly pdf version
Key Opinion Leaders: Relationship Management and Segmentation Data static version printer friendly pdf version
Key Players in Pharmaceutical Contract Manufacturing: Market Developme... static version printer friendly pdf version
Key Sub-Saharan African Infectious Disease Pharmaceutical Markets static version printer friendly pdf version
Key Trends Fueling the Boom in Genetic Testing static version printer friendly pdf version
Key Trends In Drug-diagnostic Co-Development: Identifying Collaborativ... static version printer friendly pdf version
Key Trends in the Asthma and Copd Market - Uncertain times for novel i... static version printer friendly
KeywordPharma Conference Insights - Drug Safety for Marketed Drugs static version printer friendly pdf version
KeywordPharma Conference Insights - Marketing ROI for Pharma static version printer friendly pdf version
KeywordPharma Conference Insights - Patient Compliance Europe static version printer friendly pdf version
KeywordPharma Conference Insights - Pharma Marketing ROI static version printer friendly pdf version
KeywordPharma Conference Insights - Pharma Sales World 2007 - Advanced... static version printer friendly pdf version
KeywordPharma Conference Insights - Strategies and Solutions for Publi... static version printer friendly pdf version
Kick-Starting R&D in India: Challenges and Opportunities static version printer friendly pdf version
Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug ... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Diabetic Nephropathy Drug Pipeline... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Erectile Dysfunction Drug Pipeline... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Hyperphosphatemia Drug Pipeline Re... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Kidney Stones Drug Pipeline Report... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Overactive Bladder Drug Pipeline R... static version printer friendly pdf version
Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline... static version printer friendly pdf version
Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia static version printer friendly pdf version
Kidneys and Genito-Urinary System Diabetic Nephropathy static version printer friendly pdf version
Kidneys and Genito-Urinary System Erectile Dysfunction static version printer friendly pdf version
Kidneys and Genito-Urinary System Hyperphosphatemia static version printer friendly pdf version
Kidneys and Genito-Urinary System Kidney Stones static version printer friendly pdf version
Kidneys and Genito-Urinary System Overactive Bladder static version printer friendly pdf version
Kidneys and Genito-Urinary System Urinary Incontinence static version printer friendly pdf version
Kinase Screening & Profiling Trends 2008 Market Report static version printer friendly pdf version
Kinases: Advanced Strategies and Multiple Targets for Drug Discovery static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Kuwait Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
^ Top
L
Label Free Binding Analysis Trends 2008 Market Report static version printer friendly pdf version
Laboratory Equipment Market Report 2008 static version printer friendly pdf version
Lacidipine static version printer friendly pdf version
Lacidipine - Pipeline Developer static version printer friendly pdf version
Lamivudine - Pipeline Developer static version printer friendly pdf version
Lamivudine - Pipeline Selector static version printer friendly pdf version
Lamotrigine - Pipeline Developer static version printer friendly pdf version
Lamotrigine - Pipeline Selector static version printer friendly pdf version
Lansoprazole - Pipeline Developer static version printer friendly pdf version
Lansoprazole - Pipeline Selector static version printer friendly pdf version
Lapatinib - Pipeline Developer static version printer friendly pdf version
Lapatinib - Pipeline Selector static version printer friendly pdf version
Large Pharma: 2004 A Year Of Progress static version printer friendly
Latanoprost - Pipeline Developer static version printer friendly pdf version
Latanoprost - Pipeline Selector static version printer friendly pdf version
Late Stage Anti-hypertensives R&D Update - Critical Factors for Succes... static version printer friendly pdf version
Latest Chinese Regulations for Imported Drug Registration: A Comprehen... static version printer friendly pdf version
Latin American Markets for Incontinence Devices static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Latvia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Launching a Medicine or a Product in French Pharmacies static version printer friendly pdf version
Leachables and Extractables - 2009 Conference Proceedings static version printer friendly pdf version
Lead Optimization Strategies: Future Developments, Threats and Opportu... static version printer friendly pdf version
Leading Cardiovascular Players 2002 - Portfolios Requiring Replacement... static version printer friendly pdf version
Leading Life Science Intermediates Companies Collaborations static version printer friendly pdf version
Leading Life Science Intermediates Companies Comparative Analysis static version printer friendly pdf version
Leading Life Science Intermediates Companies Financial Analyses static version printer friendly pdf version
Leading Life Science Intermediates Companies Marketing Tactics static version printer friendly pdf version
Leading Life Science Intermediates Companies Organizations and Managem... static version printer friendly pdf version
Leading Life Science Intermediates Companies Product Portfolio Analyse... static version printer friendly pdf version
Leading Life Science Intermediates Companies R&D Expenditures and Majo... static version printer friendly pdf version
Leading Life Science Intermediates Companies Strategic Directions static version printer friendly pdf version
Leading Life Science Intermediates Companies Technological Know-How static version printer friendly pdf version
Leading Pharmaceutical Companies Business Organizations and Senior Man... static version printer friendly pdf version
Leading Pharmaceutical Companies Collaborative Arrangements static version printer friendly pdf version
Leading Pharmaceutical Companies Comparative Analysis static version printer friendly pdf version
Leading Pharmaceutical Companies Financial Analyses static version printer friendly pdf version
Leading Pharmaceutical Companies Marketing Tactics static version printer friendly pdf version
Leading Pharmaceutical Companies Product Portfolio Analyses static version printer friendly pdf version
Leading Pharmaceutical Companies R&D Expenditures and Major Programs static version printer friendly pdf version
Leading Pharmaceutical Companies Strategic Directions static version printer friendly pdf version
Leading Pharmaceutical Companies Technological Know-How static version printer friendly pdf version
Lebanon Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Lebanon Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Leflunomide - Pipeline Developer static version printer friendly pdf version
Leflunomide - Pipeline Selector static version printer friendly pdf version
Legal and Regulatory Issues in eHealth Security: An Overview of Europe... static version printer friendly
Legal Aspects of Outsourcing in the Pharmaceutical Industry: A Practic... static version printer friendly
Legislation and Industry Status of Human Organ Transplantation static version printer friendly pdf version
Lercanidipine - Pipeline Developer static version printer friendly pdf version
Lercanidipine - Pipeline Selector static version printer friendly pdf version
Letrozole - Pipeline Developer static version printer friendly pdf version
Letrozole - Pipeline Selector static version printer friendly pdf version
Levetiracetam - Pipeline Developer static version printer friendly pdf version
Levetiracetam - Pipeline Selector static version printer friendly pdf version
Levocetirizine - Pipeline Developer static version printer friendly pdf version
Levocetirizine - Pipeline Selector static version printer friendly pdf version
Levofloxacin - Pipeline Developer static version printer friendly pdf version
Levofloxacin - Pipeline Selector static version printer friendly pdf version
Levosalbutamol - Pipeline Selector static version printer friendly pdf version
Levothyroxine sodium - Pipeline Selector static version printer friendly pdf version
Licensing Strategies - Examining Today’s Pharmaceutical Licensing Tren... static version printer friendly pdf version
Licensing Strategies for Accessing Biomarker Technologies static version printer friendly pdf version
Licensing Strategies: Trends In The Top 20 Pharmaceutical Companies Ac... static version printer friendly pdf version
Life Expectancy Rate by Country, 2008 static version printer friendly pdf version
Life Sciences Industry: Quarterly Deal Review - Second Quarter 2005 static version printer friendly pdf version
Life Sciences Industry: Quarterly Deal Review -Third Quarter 2005 static version printer friendly pdf version
Life Sciences Industry: Quarterly Deal Review--First Quarter 2005 static version printer friendly
Life Sciences Industry: Quarterly Deal Review--Fourth Quarter 2004 static version printer friendly
Lifecycle Management Strategies: Maximizing ROI through Indication Exp... static version printer friendly
Linezolid - Pipeline Developer static version printer friendly pdf version
Linezolid - Pipeline Selector static version printer friendly pdf version
Lipid Regulators - Global Strategic Business Report static version printer friendly pdf version
Lithuania Pharmaceuticals & Healthcare Report Q4 2006 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Lithuania Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Longs Drug Stores Corp. - Company Analysis static version printer friendly pdf version
Lonza: Performance, Capabilities, Goals and Strategies in the Worldwid... static version printer friendly pdf version
Looking at Chiral Technologies static version printer friendly pdf version
Looking at Offshoring in the Pharmaceutical Industry static version printer friendly pdf version
Loratadine - Pipeline Selector static version printer friendly pdf version
Losartan - Pipeline Developer static version printer friendly pdf version
Losartan - Pipeline Selector static version printer friendly pdf version
Lower Detection Limits of HBV DNA Assays static version printer friendly
Lung Cancer Rates in the U.S., 1975-2005 static version printer friendly pdf version
^ Top
M
M&A Trends in Pharma static version printer friendly pdf version
Magnetism in Medicine: A Handbook, 2nd, Completely Revised and Extende... static version printer friendly pdf version
Mail-Order Pharmacies Business Intelligence Report static version printer friendly pdf version
Major Depressive Disorder - Duloxetine - Fulfilling An Unmet Need? static version printer friendly pdf version
Malaysia - Pharmaceutical Industry Overview static version printer friendly pdf version
Malaysia Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q3 2009 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Malaysia Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Mammalian Cell Culture: Production Technologies and Market Overview static version printer friendly
Managed Cares Impact on the U.S. Pharmaceutical Market static version printer friendly pdf version
Managed Markets Account Management: Assessing the Performance of Accou... static version printer friendly pdf version
Managed Markets Market Research: Effective Structures & Activities for... static version printer friendly pdf version
Management Briefing: New Medicare 2009 Outpatient Prospective Payment ... static version printer friendly pdf version
Managing Cross-Functional Teams for Pharmaceutical Product Commerciali... static version printer friendly pdf version
Managing the Competition: Turning Competitive Intelligence into Strate... static version printer friendly pdf version
Managing Toxicology for the Future: Improving Predictive Power Through... static version printer friendly pdf version
Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics... static version printer friendly pdf version
Manufacturing and Supply Agreements in Biopharma static version printer friendly pdf version
Market Access, Pricing, and Reimbursement News in the Fourth Quarter o... static version printer friendly pdf version
Market Analysis of China Oral Diabetes Medicine --- with a Brief Analy... static version printer friendly pdf version
Market Analysis of Chinas Oral Diabetes Medicine --- With a Brief Anal... static version printer friendly
Market Dynamics: Anti-dyslipidemics - Third Generation Statins Superfl... static version printer friendly
Market Dynamics: Antipsychotics - A Market Driven by Reformulation static version printer friendly
Market Dynamics: Orthopaedic Shoulder and Small Joint Implants - Big P... static version printer friendly
Market for Tissue Implant Applications static version printer friendly pdf version
Market Opportunities and Challenges for Antibody Arrays and Beads: A M... static version printer friendly
Market Opportunity in the G-Protein Coupled Receptors (GPCRs) Target S... static version printer friendly pdf version
Market Potential for Hospital Services, Pharmaceuticals and Medical De... static version printer friendly pdf version
Market Report of Medicines for Hypertension Prevention and Cure static version printer friendly pdf version
Market Report on China’s Biopharmaceutical Industry, 2008-2010 static version printer friendly pdf version
Marketing Drugs in an Era of Pharmacovigilance - Best practice after d... static version printer friendly pdf version
Marketing Mid-Tier Pharmaceutical Brands: Winning Resources for Near-B... static version printer friendly
Marketing Pharmaceuticals to Eastern European Americans static version printer friendly
Mastering Phase IV Clinical Trials static version printer friendly pdf version
Material and Clinical Trial Requirements of Application and Approval f... static version printer friendly pdf version
Material and Clinical Trial Requirements of Application and Approval f... static version printer friendly pdf version
Material and Clinical Trial Requirements of Application and Approval f... static version printer friendly pdf version
Maximizing Investment of Returns: Analysis of Ethical Sales Growth and... static version printer friendly
Maximizing Prescribing Opportunities: Capitalizing on Primary and Seco... static version printer friendly
Maximizing Product Returns Through Reformulation: Old Molecules, New O... static version printer friendly
Measuring Ebusiness In The Pharmaceutical Sector: A Strategic Assessme... static version printer friendly
Medetomidine (Vet) - Pipeline Selector static version printer friendly pdf version
Medical Affairs Resources, Structures and Trends static version printer friendly pdf version
Medical Biosensor Applications and Market to 2008 – Diabetes Managemen... static version printer friendly pdf version
Medical Equipment and Products in Vietnam: A Strategic Reference, 2007... static version printer friendly pdf version
Medical industry, shouldering heavy responsibilities static version printer friendly pdf version
Medical Pharmacology at a Glance, 6th Edition static version printer friendly pdf version
Medical Science Liaisons: Gaining Access and Forging Relationships wit... static version printer friendly pdf version
Medicare Part D - Its impact on US drug pricing issues and role as a d... static version printer friendly
Medicare Part D: Strategies of the Leading Health Plans static version printer friendly pdf version
Medications to Treat High Blood Cholesterol static version printer friendly
Medicinal and Pharmaceutical Products in Austria: A Strategic Referenc... static version printer friendly pdf version
Medicinal Natural Products: A Biosynthetic Approach, 3rd static version printer friendly pdf version
Medicines from Animal Cell Culture static version printer friendly pdf version
mediKOL Insight - Where next for thrombosis? static version printer friendly pdf version
Meeting GMP and ISO 9001 Expectations for Product Development static version printer friendly
Mega Corporation Pipelines: A Postmerger Analysis static version printer friendly pdf version
Mega-Mergers: Executing Change in the Pharma Industry static version printer friendly pdf version
Melanoma Therapeutics: Which Strategy Will Take Us There? static version printer friendly
Meloxicam (Vet) - Pipeline Developer static version printer friendly pdf version
Meloxicam (Vet) - Pipeline Selector static version printer friendly pdf version
Meloxicam - Pipeline Developer static version printer friendly pdf version
Meloxicam - Pipeline Selector static version printer friendly pdf version
Memantine - Pipeline Developer static version printer friendly pdf version
Memantine - Pipeline Selector static version printer friendly pdf version
MemberHealth, Inc. Business Intelligence Report 2007 static version printer friendly pdf version
Merck: Performance, Capabilities, Goals and Strategies in the Worldwid... static version printer friendly pdf version
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, ... static version printer friendly pdf version
Mergers and Acquisitions Report: Pharmaceutical Industry 1995-2009 static version printer friendly pdf version
Meropenem - Pipeline Developer static version printer friendly pdf version
Meropenem - Pipeline Selector static version printer friendly pdf version
Metabolic Diseases Pipeline Analysis:Focus on Dyslipidemia, Diabetes, ... static version printer friendly
Metabolic Endocrinology - Cachexia Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology - Diabetic Neuropathy Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology - Hormone Replacement Therapy static version printer friendly pdf version
Metabolic Endocrinology - Hypercalcemia Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology - Hypocalcemia Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology - Hypogonadism Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology - Obesity Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology - Vitamin Deficiency Drug Pipeline Report static version printer friendly pdf version
Metabolic Endocrinology Cachexia static version printer friendly pdf version
Metabolic Endocrinology Diabetic Neuropathy static version printer friendly pdf version
Metabolic Endocrinology Growth Hormone Deficiency static version printer friendly pdf version
Metabolic Endocrinology Hypercalcemia static version printer friendly pdf version
Metabolic Endocrinology Hypocalcemia static version printer friendly pdf version
Metabolic Endocrinology Hypogonadism static version printer friendly pdf version
Metabolic Endocrinology Obesity static version printer friendly pdf version
Metabolic Endocrinology Type I Diabetes static version printer friendly pdf version
Metabolic Endocrinology Type II Diabetes static version printer friendly pdf version
Metabolic Endocrinology Vitamin Deficiency static version printer friendly pdf version
Metal Complex - DNA Interactions static version printer friendly pdf version
Metformin - Pipeline Selector static version printer friendly pdf version
Metronidazole - Pipeline Selector static version printer friendly pdf version
Mexican Diabetes Therapy Market static version printer friendly pdf version
Mexico - Pharmaceutical Industry Overview static version printer friendly pdf version
Mexico Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Mexico Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Mexico Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Mexico Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Mexico Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Mexico Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Micafungin - Pipeline Developer static version printer friendly pdf version
Micafungin - Pipeline Selector static version printer friendly pdf version
MicroReaction Technology static version printer friendly pdf version
Midazolam - Pipeline Developer static version printer friendly pdf version
Midazolam - Pipeline Selector static version printer friendly pdf version
Middle East and Africa Pharma Sector Forecast to 2012 static version printer friendly pdf version
Migraine: positioning triptans in an increasingly competitive market static version printer friendly pdf version
Mild Cognitive Impairment static version printer friendly pdf version
Minimal Invasive and Non Invasive Product and Service Market (2009 - 2... static version printer friendly pdf version
Mirtazapine - Pipeline Developer static version printer friendly pdf version
Mirtazapine - Pipeline Selector static version printer friendly pdf version
Mitsubishi: PharmaVitae Profile 2005 static version printer friendly pdf version
Mixed Urinary Incontinence - An Opportunity for Novel Drug Therapies static version printer friendly
Modafinil - Pipeline Developer static version printer friendly pdf version
Modafinil - Pipeline Selector static version printer friendly pdf version
Modern Phytomedicine: Turning Medicinal Plants into Drugs static version printer friendly pdf version
Modified Nucleosides: in Biochemistry, Biotechnology and Medicine static version printer friendly pdf version
Moldova Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Moldova Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Moldova Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Molecule Insight - Simvastatin static version printer friendly
Molecule Insight -Aluminum Hydroxide Gel static version printer friendly pdf version
Molecule Insight -Reopro static version printer friendly pdf version
Molecule Insight -Trazadone static version printer friendly pdf version
Molecules and Medicine static version printer friendly pdf version
Molecules That Changed the World static version printer friendly pdf version
Mometasone - Pipeline Developer static version printer friendly pdf version
Mometasone - Pipeline Selector static version printer friendly pdf version
Monitoring and Ensuring Pharmaceutical Compliance static version printer friendly pdf version
Monoclonal Antibodies 2007: Competitive Landscape & Pipeline Insight static version printer friendly pdf version
Monoclonal Antibodies: What the Future Holds static version printer friendly pdf version
Monoclonal Antibody - Industry Background and Company News Updates static version printer friendly
Monoclonal Antibody Therapies: Evolving Into A $30 Billion Market static version printer friendly
Monoclonal Antibody Therapies: Sector Analysis Tool static version printer friendly
Montelukast - Pipeline Developer static version printer friendly pdf version
Montelukast - Pipeline Selector static version printer friendly pdf version
Morocco Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Morocco Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Morocco Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Morocco Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Movement Disorders: Niche Markets Offering Commercial Opportunities Fo... static version printer friendly pdf version
Moxidectin (Vet) - Pipeline Developer static version printer friendly pdf version
Moxidectin (Vet) - Pipeline Selector static version printer friendly pdf version
Moxifloxacin - Pipeline Developer static version printer friendly pdf version
Moxifloxacin - Pipeline Selector static version printer friendly pdf version
Multinationals at the Gate: Best Indian Cities for Locating your R&D C... static version printer friendly
Multiple Myeloma Therapeutics - US Market Trends & Analysis static version printer friendly pdf version
Multiple Sclerosis - Industry Background and Company News Updates static version printer friendly
Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs static version printer friendly pdf version
Musculo-Skeletal-Disorders - Gout Drug Pipeline Report static version printer friendly pdf version
Musculo-Skeletal-Disorders - Muscle Pain Drug Pipeline Report static version printer friendly pdf version
Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report static version printer friendly pdf version
Musculo-Skeletal-Disorders Gout static version printer friendly pdf version
Musculo-Skeletal-Disorders Muscle Pain static version printer friendly pdf version
Musculo-Skeletal-Disorders Osteoarthritis static version printer friendly pdf version
Musculo-Skeletal-Disorders Osteoporosis static version printer friendly pdf version
Mycophenolic Acid - Pipeline Developer static version printer friendly pdf version
Mycophenolic Acid - Pipeline Selector static version printer friendly pdf version
Myelodysplastic Syndrome - An Underserved Population Offers Commercial... static version printer friendly
^ Top
N
Named Patient Drug Import - Legislation and Procedures in Lithuania static version printer friendly pdf version
Nano Chromatography and Capillary Electrophoresis: Pharmaceutical and ... static version printer friendly pdf version
Nanobiotechnology And Nanobiosciences static version printer friendly pdf version
Nanocatalysts--Application Impact Analysis (Technical Insights) static version printer friendly pdf version
Nanomedicine - Global Strategic Business Report static version printer friendly pdf version
Nanoparticle Drug Delivery Market Report static version printer friendly pdf version
Nanopathology: The Health Impact of Nanoparticles static version printer friendly pdf version
Nanotechnology for Drug Discovery and Drug Design static version printer friendly
Nanotechnology in Medicine: Its Time Has Come static version printer friendly
Nanotoxicity: From In Vivo and In Vitro Models to Health Risks static version printer friendly pdf version
Naratriptan - Pipeline Developer static version printer friendly pdf version
Naratriptan - Pipeline Selector static version printer friendly pdf version
Nateglinide - Pipeline Developer static version printer friendly pdf version
Nateglinide - Pipeline Selector static version printer friendly pdf version
Nebivolol - Pipeline Developer static version printer friendly pdf version
Nebivolol - Pipeline Selector static version printer friendly pdf version
Negotiating the Emerging Biosimilars Landscape: Key Developments in th... static version printer friendly pdf version
Netherlands Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Netherlands Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Netherlands Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Netherlands Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Netherlands Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Neurodegenerative Market Forecast to 2013 static version printer friendly pdf version
Neurological Monitors Market, 1998-2008 static version printer friendly pdf version
Neuropathic Pain: Treatments and Prescribing Practices - A Global Surv... static version printer friendly pdf version
Neuroprotective Agents: Eighth International Neuroprotection Society M... static version printer friendly pdf version
Neurostimulation - Advanced Technologies and Global Market (2009 - 201... static version printer friendly pdf version
New Approaches to Pharma R&D: Evolving Strategies to Rejuvenate R&D Ef... static version printer friendly pdf version
New Drug Approval in Japan static version printer friendly
New Drug Approval in the European Union static version printer friendly
New Drug Development from Existing Drugs static version printer friendly pdf version
New Drug Futures 2009 static version printer friendly
New Frontiers in Asymmetric Catalysis static version printer friendly pdf version
New Strategies in Pharmaceutical Academic-Industry Collaborations static version printer friendly pdf version
New Therapies for Pulmonary Arterial Hypertension: Orphan Drugs Seekin... static version printer friendly
New Types of HIV Drugs static version printer friendly pdf version
Nexium Case Study: Using Public Relations to Reach Diverse Patient Pop... static version printer friendly pdf version
Next Generation Protein Engineering and Drug Design: Strategies to boo... static version printer friendly pdf version
Nicorandil - Pipeline Developer static version printer friendly pdf version
Nicorandil - Pipeline Selector static version printer friendly pdf version
Nigeria - Pharmaceutical Industry Overview static version printer friendly pdf version
Nigeria Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Nigeria Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Nigeria Pharmaceuticals and Healthcare Report Q1 2010 static version printer friendly pdf version
Nigeria Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Nigeria Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Nigeria Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Nigeria Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
NIRS: Emerging Living Tissue Monitors static version printer friendly pdf version
Nordic Life Science Industry Guide 2008 static version printer friendly pdf version
Nordic Pharma Development 2004 static version printer friendly
North America Pharmaceuticals Sectors : A Company and Industry Analysi... static version printer friendly pdf version
North American and Western Europe Oral Solid Drug Dosage Excipients static version printer friendly pdf version
North American Fine Chemicals Market: Investment Analysis static version printer friendly pdf version
North American OE Suspension Systems and Modules Markets static version printer friendly pdf version
North China Pharmaceutical: A Company Analysis static version printer friendly
Novartis: Performance, Capabilities, Goals and Strategies in the World... static version printer friendly pdf version
Novasep: Performance, Capabilities, Goals and Strategies in the Worldw... static version printer friendly pdf version
Nuclear and Particle Physics: An Introduction, 2nd Edition static version printer friendly pdf version
Nuclear Medicine - A Global Update of Market Trends & Opportunities static version printer friendly pdf version
Nuclear Medicine - Global Strategic Business Report static version printer friendly
Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine static version printer friendly pdf version
Number of FDA “Black-box” Warnings, 2003-2007 static version printer friendly pdf version
Number of New Drugs Approved by the FDA, 1996-2003 static version printer friendly pdf version
Number Uninsured and Uninsured Rate in the U.S., 1987-2006 static version printer friendly pdf version
Nutraceuticals - Industry Background and Company News Updates static version printer friendly
Nutraceuticals in China and Japan: Emerging Opportunities and their Cr... static version printer friendly pdf version
Nutraceuticals in France static version printer friendly pdf version
Nutraceuticals in Germany static version printer friendly pdf version
Nutraceuticals in Japan static version printer friendly pdf version
Nutraceuticals in the United Kingdom static version printer friendly pdf version
Nutraceuticals in the United States static version printer friendly
Nutraceuticals Market Assessment 2008 static version printer friendly pdf version
Nutraceuticals: Global Industry Guide static version printer friendly pdf version
Nutritional Supplement Industry: Impact of Changing Lifestyle static version printer friendly pdf version
^ Top
O
Obesity Drug Discoveries: What the Future Holds static version printer friendly pdf version
Obesity Drug Discoveries: What The Future Holds + Obesity Tracker static version printer friendly pdf version
Obesity Drug Markets in the US and EU: Analysis of Product Pipelines a... static version printer friendly pdf version
Octreotide - Pipeline Developer static version printer friendly pdf version
Octreotide - Pipeline Selector static version printer friendly pdf version
Off-Label Prescribing: Overcoming the Reimbursement Barrier static version printer friendly
Olanzapine - Pipeline Developer static version printer friendly pdf version
Olanzapine - Pipeline Selector static version printer friendly pdf version
Old People Care in Institutions static version printer friendly
Olmesartan - Pipeline Developer static version printer friendly pdf version
Olmesartan - Pipeline Selector static version printer friendly pdf version
Olopatadine - Pipeline Developer static version printer friendly pdf version
Olopatadine - Pipeline Selector static version printer friendly pdf version
Oman Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Oman Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Oman Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Oman Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Oman Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Oman Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Oman Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Oman Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
Omega-3-acid ethyl esters - Pipeline Developer static version printer friendly pdf version
Omega-3-acid ethyl esters - Pipeline Selector static version printer friendly pdf version
Omeprazole - Pipeline Developer static version printer friendly pdf version
Omeprazole - Pipeline Selector static version printer friendly pdf version
Omnicare Business Intelligence Report 2007 static version printer friendly pdf version
Oncology Review 2002 - Biotechnology Niche Product Positioning Begins ... static version printer friendly pdf version
Ondansetron - Pipeline Developer static version printer friendly pdf version
Ondansetron - Pipeline Selector static version printer friendly pdf version
Online Clinical Care Tools: Promoting Treatment Tools to Physicians in... static version printer friendly pdf version
Online Clinical Trial Recruitment: Strategies for Driving Participatio... static version printer friendly
Online Continuing Medical Education: Trends in the US and European eCM... static version printer friendly
Online Disease Management: Improving patient care and product position... static version printer friendly
Online Healthcare Communities: Opportunities for Accessing Consumers static version printer friendly
Online Patient Compliance Tools: Using the Internet to Improve Outcome... static version printer friendly pdf version
Online Pharmaceutical Directory for Contract Manufacturing Organizatio... static version printer friendly pdf version
Online Proxy Care: Reaching Caregivers Through the Internet static version printer friendly
Operating tools for transgenic manufacturers static version printer friendly pdf version
Operational CRM: Leveraging oCRM Technologies in the Pharmaceutical In... static version printer friendly pdf version
Ophthalmic Pharmaceutical Drugs - A Global Market Perspective static version printer friendly pdf version
Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report static version printer friendly pdf version
Ophthalmology and Optometry - Conjunctivitis Drug Pipeline Report static version printer friendly pdf version
Ophthalmology and Optometry - Dry Eyes Drug Pipeline Report static version printer friendly pdf version
Ophthalmology and Optometry - Eye Infections Drug Pipeline Report static version printer friendly pdf version
Ophthalmology and Optometry - Glaucoma Drug Pipeline Report static version printer friendly pdf version
Ophthalmology and Optometry - Macular Degeneration Drug Pipeline Repor... static version printer friendly pdf version
Ophthalmology and Optometry - Ocular Inflammation Drug Pipeline Report... static version printer friendly pdf version
Ophthalmology and Optometry Conjunctivitis static version printer friendly pdf version
Ophthalmology and Optometry Dry Eyes static version printer friendly pdf version
Ophthalmology and Optometry Eye Infections static version printer friendly pdf version
Ophthalmology and Optometry Glaucoma static version printer friendly pdf version
Ophthalmology and Optometry Macular Degeneration static version printer friendly pdf version
Ophthalmology and Optometry Ocular Inflammation static version printer friendly pdf version
Opinions in Uterine Fibroid Management: Is there a need for pharmacolo... static version printer friendly
Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil... static version printer friendly pdf version
Opportunities and Challenges for Generic Drugs in Australia static version printer friendly pdf version
Opportunities and Challenges for Generic Drugs in the UK 2007 static version printer friendly pdf version
Opportunities and Challenges in Emerging U.S. Geriatric Drug Markets static version printer friendly
Opportunities and Challenges in the Adult Attention-Deficit/Hyperactiv... static version printer friendly
Opportunities Assessment for Diabetes Therapeutics - Australia static version printer friendly pdf version
Opportunities Assessment for Diabetes Therapeutics Market-Taiwan static version printer friendly pdf version
Opportunities Assessment for Diabetes Therapeutics: South Korea static version printer friendly pdf version
Opportunities for European Pharmaceutical and Biotechnology Companies ... static version printer friendly pdf version
Opportunities in Indian Pharma Sector static version printer friendly
Opportunities in Menopausal Treatments: Will New Therapies Overtake Ho... static version printer friendly pdf version
Opportunities in the Indian Pharmaceuticals Industry static version printer friendly pdf version
Opportunities in the Pharmacotherapy of Addiction static version printer friendly pdf version
Opportunity Analysis of the U.S. Tele-Health Solutions Market static version printer friendly pdf version
Optimal Strategies for Marketing Pharmaceuticals to Eastern European A... static version printer friendly
Optimizing Key Opinion Leader Relationships: Best Practices in KOL Man... static version printer friendly pdf version
Optimizing Licensing Strategies for the 21st Century: Creating Win-Win... static version printer friendly
Optimizing Partnerships with Contract Organizations: Effective Managem... static version printer friendly pdf version
Optimizing PLM Technology for the Pharmaceutical Industry (Technology ... static version printer friendly pdf version
Optimizing Portfolio Management: Strategies to Deliver Corporate Succe... static version printer friendly
Optimizing Sales Force Effectiveness - From Quantity to Quality static version printer friendly pdf version
Optimizing Synthetic RNAi: Perspectives from the Pharmaceutical and Bi... static version printer friendly pdf version
Option and Evaluation Agreements in Pharma and Biotech static version printer friendly pdf version
Optoelectronic Sensors static version printer friendly pdf version
Orlistat - Pipeline Developer static version printer friendly pdf version
Orlistat - Pipeline Selector static version printer friendly pdf version
Orphan Disease Series - Glaucoma: Can Orphan-Drug Status Offer an Entr... static version printer friendly pdf version
Orphan Drug Strategies static version printer friendly pdf version
Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help O... static version printer friendly pdf version
Orphan Drugs Pipeline Analysis: Wider Incentives Encourage Orphan Drug... static version printer friendly
Orthopedic Postoperative Pain - Old Habits Hurt Market Potential static version printer friendly
Osteoarthritis - Preconceptions Damage Awareness and Treatments static version printer friendly
Osteoporosis - The Science Of Compliance static version printer friendly pdf version
Osteoporosis Therapeutics - A Global Market Perspective static version printer friendly pdf version
Osteoporosis Therapeutics - Global Strategic Business Report static version printer friendly
OTC Company Profile - Bayer AG static version printer friendly
OTC Company Profile - Boots Company Plc static version printer friendly
OTC Company Profile - Herbal Life Int. Inc static version printer friendly
OTC Company Profile - Merck KGaA static version printer friendly
OTC Company Profile - Novartis AG static version printer friendly
OTC Company Profile - Rochel Holding AG static version printer friendly
OTC Company Profile - Schering Plough Corp static version printer friendly
OTC Company Profile - Taisho Parmaceutical static version printer friendly
OTC Company Profile: Otsuka Pharmaceutical static version printer friendly
OTC Healthcare Company Profile - Aventis static version printer friendly
OTC Healthcare Company Profile - Boehringer static version printer friendly pdf version
OTC Healthcare Company Profile - Bristol Myer Squibb static version printer friendly pdf version
OTC Healthcare Company Profile - Glaxo SmithKline Plc static version printer friendly pdf version
OTC Healthcare Company Profile - NuSkin Enterprises static version printer friendly pdf version
OTC Healthcare Company Profile - Sanofi Synthelabo France SA static version printer friendly
OTC Healthcare in Algeria static version printer friendly pdf version
OTC Healthcare in Ecuador static version printer friendly pdf version
OTC Healthcare in Macedonia static version printer friendly pdf version
OTC Healthcare in The United Arab Emirates static version printer friendly pdf version
OTC Market in Poland 2007 Development Forecasts 2007-2009 static version printer friendly pdf version
OTC Market in Poland 2007 Development Forecasts 2007-2009 static version printer friendly pdf version
OTC Pharmaceuticals Market Report static version printer friendly
OTC Pharmaceuticals Market Report 2008 static version printer friendly pdf version
Outlook 2009 - Global Pharmaceutical and Biotechnology Markets static version printer friendly pdf version
Outlook for eDetailing: What Does Next Generation eDetailing Look Like... static version printer friendly pdf version
Outsourcing Chemistry Services Made Easy static version printer friendly pdf version
Outsourcing Clinical Development static version printer friendly
Outsourcing Clinical Trials: A Global Analytical Guide and Comparative... static version printer friendly pdf version
Over-the-Counter Pharmaceuticals in China: A Market Analysis 2006 static version printer friendly pdf version
Over-the-Counter Pharmaceuticals in China: Company Profiles 2006 static version printer friendly pdf version
Overview of Pharmaceutical and Medical Devices Industry in Russia and ... static version printer friendly pdf version
Overview of the Bulgarian and Romanian Pharmaceutical Markets static version printer friendly
Overview of the European Drug Discovery Market static version printer friendly pdf version
Oxaliplatin - Pipeline Developer static version printer friendly pdf version
Oxaliplatin - Pipeline Selector static version printer friendly pdf version
Oxford Handbook of Clinical Pharmacy, First Edition static version printer friendly pdf version
Oxford Handbook of Glaucoma Medical Therapy: Principles and Management... static version printer friendly pdf version
Oxford Handbook of Nurse Prescribing, First Edition static version printer friendly pdf version
Oxford Handbook of Plum and Posner's Diagnosis of Stupor and Coma, Fou... static version printer friendly pdf version
Oxford Handbook of Rehabilitation Medicine, First Edition static version printer friendly pdf version
Oxford Handbook of Rheumatology, Second Edition static version printer friendly pdf version
Oxford Handbook of Tropical Medicine, Second Edition static version printer friendly pdf version
Oxford Renewing the Stuff of Life : Stem Cells, Ethics, and Public Pol... static version printer friendly pdf version
Oxford Streptomyces in Nature and Medicine: The Antibiotic Makers static version printer friendly pdf version
Oxidative Medicine & Cellular Longevity Journal static version printer friendly pdf version
^ Top
P
Paclitaxel - Pipeline Developer static version printer friendly pdf version
Paclitaxel - Pipeline Selector static version printer friendly pdf version
Pain Drugs: Problems and Opportunities static version printer friendly pdf version
Pain in Osteoarthritis static version printer friendly pdf version
Pain Management - Evaluation and Treatment Issues, 2nd Edition (2009 u... static version printer friendly pdf version
Pain Therapeutics - Drugs, Markets and Companies static version printer friendly
Pain Therapeutics: New Times, New Targets static version printer friendly pdf version
Pakistan Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Pakistan Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Pakistan Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Pakistan Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Pakistan Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Pakistan Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Palonosetron - Pipeline Selector static version printer friendly pdf version
Pantoprazole - Pipeline Developer static version printer friendly pdf version
Pantoprazole - Pipeline Selector static version printer friendly pdf version
Parallel Trade in Europe and the US: The Challenges Facing Pharma static version printer friendly pdf version
Paricalcitol - Pipeline Developer static version printer friendly pdf version
Paricalcitol - Pipeline Selector static version printer friendly pdf version
Parkinson's Disease Biomarkers: Vital Tools for Neuroprotectants static version printer friendly pdf version
Parkinson's Disease Presents Lucrative Market Opportunities static version printer friendly
Paroxetine - Pipeline Developer static version printer friendly pdf version
Paroxetine - Pipeline Selector static version printer friendly pdf version
Part 11 and Drug Development: A Q&A Reference Guide static version printer friendly
Patent Law and Practice in Pharmaceuticals static version printer friendly pdf version
Patent Protection Strategies: Maximising Product Revenues static version printer friendly pdf version
Patents in the Postgenomic Era: Proprietary Drug Targets and Therapies... static version printer friendly
Patient Power Outlook 2001 static version printer friendly pdf version
Paving the Difficult Road to Universal Insurance Coverage: Spotlight o... static version printer friendly pdf version
Pediatric Radiology Review: The Society for Pediatric Radiology static version printer friendly pdf version
Pegfilgrastim - Pipeline Developer static version printer friendly pdf version
Pegfilgrastim - Pipeline Selector static version printer friendly pdf version
Pemetrexed - Pipeline Developer static version printer friendly pdf version
Pemetrexed - Pipeline Selector static version printer friendly pdf version
Penciclovir - Pipeline Developer static version printer friendly pdf version
Penciclovir - Pipeline Selector static version printer friendly pdf version
Peptides 2006 - New Applications in Discovery, Manufacturing, and Ther... static version printer friendly
Percentage Breakdown of U.S. Healthcare Spending, 2008 static version printer friendly pdf version
Percentage of Adults Smokers by Country, 2008 static version printer friendly pdf version
Percentage of GDP Healthcare Spending by Country, 2008 static version printer friendly pdf version
Percentage of Population Without Health Insurance in the U.S., 2007 static version printer friendly pdf version
Percentage of U.S. Population Five-Year Cancer Survival Rates, 1975-20... static version printer friendly pdf version
Percentage of U.S. Population that Is Overweight, 1976-2004 static version printer friendly pdf version
Percentage of U.S. Population that Smokes, 1965-2007 static version printer friendly pdf version
Performance Benchmark: Optimizing Marketing Staff Levels to Drive Grow... static version printer friendly pdf version
Pergolide - Pipeline Developer static version printer friendly pdf version
Pergolide - Pipeline Selector static version printer friendly pdf version
Perindopril - Pipeline Developer static version printer friendly pdf version
Perindopril - Pipeline Selector static version printer friendly pdf version
Peripheral Arterial Disease static version printer friendly
Peripheral Neuropathy and Neuropathic Pain static version printer friendly pdf version
Personalized Medicine - Scientific and Commercial Aspects static version printer friendly
Peru Pharmaceuticals and Healthcare Report Q1 2008 static version printer friendly pdf version
Peru Pharmaceuticals and Healthcare Report Q1 2009 static version printer friendly pdf version
Peru Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Peru Pharmaceuticals and Healthcare Report Q2 2009 static version printer friendly pdf version
Peru Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Peru Pharmaceuticals and Healthcare Report Q3 2008 static version printer friendly pdf version
Peru Pharmaceuticals and Healthcare Report Q4 2008 static version printer friendly pdf version
Peru Pharmaceuticals and Healthcare Report Q4 2009 static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in Australia static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in Brazil static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in Canada static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in China static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in France static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in Germany static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in India static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in Japan static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in Russia static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in United Kingdom static version printer friendly pdf version
PEST Analysis - Pharmaceuticals Sector in United States static version printer friendly pdf version
Pfizer - Pipeline - Products - Performance - Potential static version printer friendly pdf version
Pfizer Corporation Drug Patent Expiration Years static version printer friendly
Pfizer: Performance, Capabilities, Goals and Strategies in the Worldwi... static version printer friendly pdf version
Pharma and the Feds: Key Government Activities and How They Affect the... static version printer friendly pdf version
Pharma Antes Up: Investment and Business Trends Driving Biotechnology static version printer friendly pdf version
Pharma Business Management in India static version printer friendly pdf version
Pharma Industry Portal static version printer friendly pdf version
Pharma Industry Statistics in India static version printer friendly pdf version
Pharma Market Authorization Strategies: A Guide To Launching Drugs Qui... static version printer friendly
Pharma Poland News static version printer friendly
Pharma Poland Online static version printer friendly pdf version
Pharma Sales Force Effectiveness: Increasing Productivity Through Stre... static version printer friendly pdf version
Pharma's Changing Business Strategies: Five Deadly Pharma Sins static version printer friendly pdf version
Pharma-Ecology: The Occurrence and Fate of Pharmaceuticals and Persona... static version printer friendly pdf version
Pharma/Medical Device/Diagnostics Licensing and Collaborations – Evalu... static version printer friendly
Pharmaceutical & Medicine Manufacturing in the US static version printer friendly
Pharmaceutical (Japan) - Portfolio Analysis static version printer friendly pdf version
Pharmaceutical (Japan) - Portfolio Analysis static version printer friendly pdf version
Pharmaceutical Alliance Management static version printer friendly pdf version
Pharmaceutical and Healthcare Market in Poland 2009 - Development Fore... static version printer friendly pdf version
Pharmaceutical and Healthcare Market in Poland 2009 - Development Fore... static version printer friendly pdf version
Pharmaceutical and Medicine Manufacturing in China static version printer friendly pdf version
Pharmaceutical and Medicine Manufacturing Industry in the U.S. and its... static version printer friendly pdf version
Pharmaceutical and Toiletry Wholesaling in Australia static version printer friendly
Pharmaceutical Applications of Raman Spectroscopy static version printer friendly pdf version
Pharmaceutical Biotechnology: Concepts and Applications static version printer friendly pdf version
Pharmaceutical Branding Strategies: Thought Leader Perspectives On Bra... static version printer friendly
Pharmaceutical Calculations, 4th Edition static version printer friendly
Pharmaceutical CME: Measuring Program Effectiveness in the Compliance ... static version printer friendly pdf version
Pharmaceutical Co-Promotion Management static version printer friendly
Pharmaceutical Companies 2000: Strategic Analysis and Future Perspecti... static version printer friendly
Pharmaceutical Companies and Technology Vendors: Partners in eBusiness... static version printer friendly
Pharmaceutical Companies: Current Status and Prospects for Generic Dru... static version printer friendly
Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Co... static version printer friendly pdf version
Pharmaceutical Contract Manufacturing - Global Market Trends static version printer friendly pdf version
Pharmaceutical Contract Manufacturing - Global Strategic Business Repo... static version printer friendly pdf version
Pharmaceutical Contract Manufacturing 2003 - Japan static version printer friendly
Pharmaceutical Contract Manufacturing 2004 static version printer friendly
Pharmaceutical Contract Manufacturing 2005 static version printer friendly
Pharmaceutical Contract Manufacturing and API Sourcing In Central and ... static version printer friendly pdf version
Pharmaceutical Counterfeiting in the EU: Where Are We Now? static version printer friendly pdf version
Pharmaceutical Customer Relationship Management: Developing and Improv... static version printer friendly pdf version
Pharmaceutical Deal Structures - The Essential Manual for Deal Makers static version printer friendly
Pharmaceutical Distribution in Europe: Pfizer Breaks the Mold static version printer friendly pdf version
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China... static version printer friendly pdf version
Pharmaceutical Growth Opportunities in the EU Accession States: Health... static version printer friendly pdf version
Pharmaceutical Industry in Belgium static version printer friendly pdf version
Pharmaceutical Industry in Brazil static version printer friendly pdf version
Pharmaceutical Industry in China static version printer friendly pdf version
Pharmaceutical Industry in China - PEST Framework Analysis static version printer friendly pdf version
Pharmaceutical Industry in China, 2004-2005 static version printer friendly pdf version
Pharmaceutical Industry in Czech Republic static version printer friendly pdf version
Pharmaceutical Industry in Denmark static version printer friendly pdf version
Pharmaceutical Industry in Germany static version printer friendly pdf version
Pharmaceutical Industry in Hungary static version printer friendly pdf version
Pharmaceutical Industry in India - PEST Framework Analysis static version printer friendly pdf version
Pharmaceutical Industry in India - Porter's Five Forces Strategy Analy... static version printer friendly pdf version
Pharmaceutical Industry in Italy static version printer friendly pdf version
Pharmaceutical Industry in Japan static version printer friendly pdf version
Pharmaceutical Industry in Mexico static version printer friendly pdf version
Pharmaceutical Industry in Norway static version printer friendly pdf version
Pharmaceutical Industry in Poland static version printer friendly pdf version
Pharmaceutical Industry in Russia static version printer friendly pdf version
Pharmaceutical Industry in South Africa static version printer friendly pdf version
Pharmaceutical Industry in South Korea static version printer friendly pdf version
Pharmaceutical Industry in Spain static version printer friendly pdf version
Pharmaceutical Industry in Sweden static version printer friendly pdf version
Pharmaceutical Industry in Taiwan static version printer friendly pdf version
Pharmaceutical Industry in the Netherlands static version printer friendly pdf version
Pharmaceutical Industry in the United States static version printer friendly pdf version
Pharmaceutical Industry in the United States - Porter's Five Forces St... static version printer friendly pdf version
Pharmaceutical Industry in UK - Porter's Five Forces Strategy Analysis... static version printer friendly pdf version
Pharmaceutical Industry Market Review 2008 static version printer friendly pdf version
Pharmaceutical Innovation Through Academic Allia | |